Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21266697 | 0.82 | CTSS (0.39) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL19385609 | 0.77 | CTSK (0.40) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL1337408 | 0.76 | CTSS (0.40) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL19088611 | 0.76 | CTSS (0.37) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL25183012 | 0.76 | CTSS (0.40) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL8269704 | 0.75 | CTSS (0.36) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL29097283 | 0.75 | AAK1 (0.33) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL23519021 | 0.72 | CTSS (0.34) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL25179484 | 0.71 | CTSK (0.39) | CTSSCTSKMMP13AAK1 | |
| SCHEMBL30639521 | 0.71 | CTSK (0.41) | CTSSCTSKMMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11230571-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-01-25 | — | — | US | disclosed |
| US-20190248840-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248840-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | CTSS 264/4885CTSK 185/4885MMP13 440/4885 |
| US-11230571-B2 | Anthelmintic depsipeptide compounds | VIP, PREP, DNPEP | CTSS 264/4885CTSK 185/4885MMP13 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.